Stuart A. Arbuckle, EVP, COO: Vertex Pharmaceuticals VRTX Sell · Filed 23/02/16

Trade details

Type: Insider sale
Amount: $599,157.39
Shares · price: 2,003 sh · $299.13 a share
Held after: 77,739 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Stuart A. ArbuckleEVP, COO
Trade date: 23/02/14
Filed: 23/02/16
Days to filing: 2 days

Sold 2.5% of holdings

Share of holding sold: 2.5%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/15~23/03/16

Stuart A. Arbuckle's recent trades

Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$29.7K
69 sh
$29.7K
Filed 24/05/17
Traded 24/05/15
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2.1M
5,034 sh
$2.1M
Filed 24/02/27
Traded 24/02/26
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.5M
3,603 sh
$1.5M
Filed 24/02/23
Traded 24/02/21
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2M
4,804 sh
$2M
Filed 24/02/21
Traded 24/02/20
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.8M
4,295 sh
$1.8M
Filed 24/02/13
Traded 24/02/12

Stuart A. Arbuckle, COO — sold $599.2K of Vertex Pharmaceuticals VRTX · 2.5% of holdings | Whalegun